Hauwermeiren Timothy Van is a director of ITeos Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
RayzeBio, Inc.
27 Feb 24
4
RayzeBio, Inc.
1 Nov 23
3
RayzeBio, Inc.
1 Nov 23
4
iTeos Therapeutics, Inc.
15 Jun 23
4
iTeos Therapeutics, Inc.
10 Jun 22
4
iTeos Therapeutics, Inc.
21 Jun 21
4/A
iTeos Therapeutics, Inc.
21 Oct 20
4
iTeos Therapeutics, Inc.
24 Jul 20
3
iTeos Therapeutics, Inc.
23 Jul 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Feb 24 | RYZB RayzeBio | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 20.14 | 48,628 | 979.37 k | 0 |
1 Nov 23 | RYZB RayzeBio | Stock Option Common Stock | Grant | Acquire A | No | No | 20.14 | 48,628 | 979.37 k | 48,628 |
13 Jun 23 | ITOS ITeos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.77 | 22,383 | 330.60 k | 22,383 |